Entire Transcript in Adobe Acrobat Format - National Reference ...

112
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
this material and we were looking at OPRR and said, "You
know, we need to move to guidelines for IRB's because if we
let them all flounder with their various levels of
expertise we are not going to facilitate research and every
researcher who wants to use tissue is going to be up
against five different standards if he is going to five
sites for a multisite program, ten different standards if
it is ten sites for a multisite program.
So there needs to be some standardization and
what we were told is, "Well, NBAC will do this." So I feel
greatly honored to be here before NBAC in great hopes that,
in fact, you will do some of this and that will provide
guidance to the IRB's who are concerned about their ongoing
role in this area.
One of the things that we -- that was most
controversial and what we suggested that I think is very
important is that there should be a panel associated with
every tissue banking enterprise that will review protocols
that come into it so the protocol may be reviewed by the
researcher's institution that wants to support a researcher
doing certain work but tissue is a limited resource. It is
becoming very limited in breast cancer because of the size
of tumor when the tissue is taken but I am sure that this
is an issue in many other areas.